BCL2 and melanoma: Here, we report that GCNT2/I-branching significantly impairs Gal-3 binding to melanoma cell receptors, particularly β1 integrin, and diminishes Gal-3-induced ERK phosphorylation, BCL2 expression, cell proliferation, and migration.